Is EMIS undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6
Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of EMIS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: EMIS (£19.2) is trading above our estimate of fair value (£17.79)
Significantly Below Fair Value: EMIS is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for EMIS?
Key metric: As EMIS is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for EMIS. This is calculated by dividing EMIS's market cap by their current
earnings.
What is EMIS's PE Ratio?
PE Ratio
40.4x
Earnings
UK£30.48m
Market Cap
UK£1.23b
EMIS key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: EMIS is expensive based on its Price-To-Earnings Ratio (40.4x) compared to the European Healthcare Services industry average (32.5x).
Price to Earnings Ratio vs Fair Ratio
What is EMIS's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
EMIS PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
40.4x
Fair PE Ratio
33.9x
Price-To-Earnings vs Fair Ratio: EMIS is expensive based on its Price-To-Earnings Ratio (40.4x) compared to the estimated Fair Price-To-Earnings Ratio (33.9x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.